WO1994006919A3 - Cellules de mammiferes a transformation stable exprimant une cyclooxygenase inflammatoire regulee - Google Patents

Cellules de mammiferes a transformation stable exprimant une cyclooxygenase inflammatoire regulee Download PDF

Info

Publication number
WO1994006919A3
WO1994006919A3 PCT/US1993/009167 US9309167W WO9406919A3 WO 1994006919 A3 WO1994006919 A3 WO 1994006919A3 US 9309167 W US9309167 W US 9309167W WO 9406919 A3 WO9406919 A3 WO 9406919A3
Authority
WO
WIPO (PCT)
Prior art keywords
regulated
stably
cells expressing
mammalian cells
transformed mammalian
Prior art date
Application number
PCT/US1993/009167
Other languages
English (en)
Other versions
WO1994006919A2 (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NZ256776A priority Critical patent/NZ256776A/xx
Priority to AU51652/93A priority patent/AU688282B2/en
Priority to DE69324820T priority patent/DE69324820T2/de
Priority to EP93922753A priority patent/EP0667911B1/fr
Priority to JP6508460A priority patent/JPH08501690A/ja
Priority to CA002144742A priority patent/CA2144742A1/fr
Publication of WO1994006919A2 publication Critical patent/WO1994006919A2/fr
Publication of WO1994006919A3 publication Critical patent/WO1994006919A3/fr
Priority to HK98114154A priority patent/HK1013106A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/99—Miscellaneous (1.14.99)
    • C12Y114/99001—Prostaglandin-endoperoxide synthase (1.14.99.1), i.e. cyclooxygenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne une ligne de cellules transgéniques de mammifères contenant un ADN recombinant et chromosomiquement intégré, où ledit ADN exprime la G/H synthase de la prostaglandine inflammatoire régulée par glucocorticoïde (griPGHS) chez les mammifères, ou ledit ADN n'exprime pas la PGHS constitutive et où la ligne cellulaire n'exprime pas l'activité endogène de PGHS.
PCT/US1993/009167 1992-09-22 1993-09-22 Cellules de mammiferes a transformation stable exprimant une cyclooxygenase inflammatoire regulee WO1994006919A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NZ256776A NZ256776A (en) 1992-09-22 1993-09-22 Transgenic mammalian cells containing a dna sequence expressing pghs-2
AU51652/93A AU688282B2 (en) 1992-09-22 1993-09-22 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
DE69324820T DE69324820T2 (de) 1992-09-22 1993-09-22 Stabil transformierte säugertierzellen, die eine geregelte, entzündliche cyclooxygenase exprimieren
EP93922753A EP0667911B1 (fr) 1992-09-22 1993-09-22 Cellules de mammiferes a transformation stable exprimant une cyclooxygenase inflammatoire regulee
JP6508460A JPH08501690A (ja) 1992-09-22 1993-09-22 調節性炎症性シクロオキシゲナーゼを発現する安定に形質転換された哺乳動物細胞
CA002144742A CA2144742A1 (fr) 1992-09-22 1993-09-22 Cellules de mammiferes transformees de facon stable exprimant une cyclo-oxygenase inflammatoire regulee
HK98114154A HK1013106A1 (en) 1992-09-22 1998-12-21 Stably-transformed mammalian cells expressing a regulated inflammatory cyclooxygenase

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US94978092A 1992-09-22 1992-09-22
US07/949,780 1992-09-22
US98383592A 1992-12-01 1992-12-01
US07/983,835 1992-12-01
US3414393A 1993-03-22 1993-03-22
US08/034,143 1993-03-22
US5436493A 1993-04-28 1993-04-28
US08/054,364 1993-04-28

Publications (2)

Publication Number Publication Date
WO1994006919A2 WO1994006919A2 (fr) 1994-03-31
WO1994006919A3 true WO1994006919A3 (fr) 1994-05-11

Family

ID=27488184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/009167 WO1994006919A2 (fr) 1992-09-22 1993-09-22 Cellules de mammiferes a transformation stable exprimant une cyclooxygenase inflammatoire regulee

Country Status (9)

Country Link
EP (1) EP0667911B1 (fr)
JP (3) JPH08501690A (fr)
AT (1) ATE179756T1 (fr)
AU (1) AU688282B2 (fr)
CA (1) CA2144742A1 (fr)
DE (1) DE69324820T2 (fr)
HK (1) HK1013106A1 (fr)
NZ (1) NZ256776A (fr)
WO (1) WO1994006919A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
AU6029396A (en) * 1995-06-07 1996-12-30 University Of Rochester Mammalian prostaglandin h synthase-2
CA2233994A1 (fr) * 1995-10-06 1997-04-10 President And Fellows Of Harvard College Nouvelle proteine activatrice des thrombocytes
WO2001011026A1 (fr) * 1999-08-06 2001-02-15 G.D. Searle & Co. Cyclo-oxygenase-1 (cox-1) et cyclo-oxygenase-2 (cox-2) canines
DE60042456D1 (de) * 1999-10-05 2009-08-06 Japan Science & Tech Agency Testverfahren bezüglich der fettzellen und der dickleibigkeit, welches ein nicht-menschliches tier benutzt, dass ein menschliches h-pgds gen überexprimiert
WO2002066635A1 (fr) * 2001-02-23 2002-08-29 Gencom Corporation Animal transgenique possedant un gene du metabolisme des medicaments et utilisation correspondante
CN1821423B (zh) * 2005-08-19 2012-07-25 凯惠科技发展(上海)有限公司 一种抗关节炎药物细胞靶标筛选系统及筛药的方法
JP5641232B2 (ja) * 2010-11-24 2014-12-17 石川県公立大学法人 オゴノリ由来のシクロオキシゲナーゼの遺伝子及び該遺伝子を利用するプロスタグランジン類生産方法

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
COLIN D. FUNK ET AL.: "Human platelet/erythroleukemia cell porstaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment", FASEB JOURNAL, vol. 5, no. 9, June 1991 (1991-06-01), BETHESDA, MD US, pages 2304 - 2312 *
DANIEL L. SIMMONS ET AL.: "Multiple cyclooxygenases: cloning of a mitogen-inducible form", PROSTAGLANDINS, LEUKOTRIENES, LIPOXINS, AND PAF, 1991, pages 67 - 78 *
DAVID L. DEWITT ET AL.: "PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs", THE AMERICAN JOURNAL OF MEDICINE, vol. 95, no. 2A, 9 August 1993 (1993-08-09), pages 2A40S - 2A44S *
ELIZABETH A. MEADE ET AL.: "Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 9, 25 March 1993 (1993-03-25), BALTIMORE, MD US, pages 6610 - 6614 *
ELIZABETH A. MEADE ET AL.: "Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthase-2 isozymes in cos-1 cells", JOURNAL OF LIPID MEDIATORS, vol. 6, no. 1-3, March 1993 (1993-03-01), pages 119 - 129 *
M. KERRY O'BANION ET AL.: "cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 89, June 1992 (1992-06-01), WASHINGTON US, pages 4888 - 4892 *
R.P. RYSECK ET AL.: "Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity", CELL GROWTH & DIFFERENTIATION, vol. 3, no. 7, July 1992 (1992-07-01), pages 443 - 450 *
TIMOTHY HLA ET AL.: "Human cyclooxygenase-2 cDNA", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 89, no. 16, 15 August 1992 (1992-08-15), WASHINGTON US, pages 7384 - 7388 *

Also Published As

Publication number Publication date
NZ256776A (en) 1997-10-24
JPH08501690A (ja) 1996-02-27
JP2005068157A (ja) 2005-03-17
DE69324820D1 (de) 1999-06-10
HK1013106A1 (en) 1999-08-13
AU5165293A (en) 1994-04-12
ATE179756T1 (de) 1999-05-15
CA2144742A1 (fr) 1994-03-31
AU688282B2 (en) 1998-03-12
JP2004105186A (ja) 2004-04-08
WO1994006919A2 (fr) 1994-03-31
DE69324820T2 (de) 2000-01-13
EP0667911A1 (fr) 1995-08-23
EP0667911B1 (fr) 1999-05-06

Similar Documents

Publication Publication Date Title
DE69634752D1 (de) Adenovirale vektoren beinhaltend ein prostata spezifisches antigen (psa) "response element"
GB9905510D0 (en) Intracellular selection
AU545997B2 (en) High temp solid electrolyte fuel cell
AU1519488A (en) Improved solid electrolyte fuel cell and assembly
AU4266597A (en) Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
GR3022358T3 (en) Beta retinoic acid response elements compositions and assays
WO1994006919A3 (fr) Cellules de mammiferes a transformation stable exprimant une cyclooxygenase inflammatoire regulee
HUT77338A (hu) Méhnyálkahártya működésének, illetve ahhoz kapcsolódó folyamatok tökéletesítését szolgáló készítmény
AU3675095A (en) Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
HK161295A (en) Vector for integration site independent gene expression in mammalian host cells
EP1441033A3 (fr) Cassette d'expression de gènes eukaryotes dérivée du virus Herpes simplex
AU567816B2 (en) Etch metals with alcohol for nonaqueous cells
WO1999021976A3 (fr) Generation rapide de lignees cellulaires mammiferes stables produisant des niveaux eleves de proteines recombinantes
DE69227589D1 (de) Ecdysteroid-abhängige gen regulierung in säugetier-zellen
AU583471B2 (en) Hla d typing assay
AU1814995A (en) Galanin receptor, nucleic acids, transformed cells and uses thereof
WO1998032868A3 (fr) Expression de l'adn dans des cellules transfectees et dosages effectues dans des cellules transfectees
AU4853997A (en) Immortalized human corneal epithelial cell line
WO2001068831A3 (fr) Reprogrammation effective de materiel nucleaire chez des mammiferes
EP0918090A3 (fr) Cétoreductase gène et protéine de levure
IL97048A0 (en) Bioluminescence assay for gene expression in growing mammalian cells
AU2814089A (en) An input/output section for an intelligent cell which provides sensing, bidirectional communications and control
AU3085889A (en) The generation of recombinant eukaryotic cells with high- level expression
AU6154180A (en) Fluidic load cell
WO1994011510A3 (fr) Modulateurs de cellules souches hematopoietiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2144742

Country of ref document: CA

Ref document number: 256776

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1993922753

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1993922753

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1993922753

Country of ref document: EP